NCT04774328View on ClinicalTrials.gov

Preliminary Study of CA-008 (Vocacapsaicin) in Patients Undergoing Ventral Hernia Repair

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

September 9, 2020

Primary Completion Date

June 15, 2021

Study Completion Date

June 15, 2021

Conditions
Postsurgical Pain
Interventions
DRUG

CA-008 (vocacapsaicin)

Single administration of CA-008 (vocacapsaicin) versus placebo

DRUG

Placebo

Single administration of CA-008 (vocacapsaicin) versus placebo

Trial Locations (1)

77004

First Surgical Hospital, Houston

Sponsors
All Listed Sponsors
lead

Concentric Analgesics

INDUSTRY

NCT04774328 - Preliminary Study of CA-008 (Vocacapsaicin) in Patients Undergoing Ventral Hernia Repair | Biotech Hunter | Biotech Hunter